Product NDC: | 0093-3122 |
Proprietary Name: | Jinteli |
Non Proprietary Name: | norethindrone acetate and ethinyl estradiol |
Active Ingredient(s): | 5; 1 ug/1; mg/1 & nbsp; norethindrone acetate and ethinyl estradiol |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0093-3122 |
Labeler Name: | Teva Pharmaceuticals USA Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076221 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110217 |
Package NDC: | 0093-3122-42 |
Package Description: | 5 BLISTER PACK in 1 CARTON (0093-3122-42) > 28 TABLET in 1 BLISTER PACK (0093-3122-28) |
NDC Code | 0093-3122-42 |
Proprietary Name | Jinteli |
Package Description | 5 BLISTER PACK in 1 CARTON (0093-3122-42) > 28 TABLET in 1 BLISTER PACK (0093-3122-28) |
Product NDC | 0093-3122 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | norethindrone acetate and ethinyl estradiol |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20110217 |
Marketing Category Name | ANDA |
Labeler Name | Teva Pharmaceuticals USA Inc |
Substance Name | ETHINYL ESTRADIOL; NORETHINDRONE ACETATE |
Strength Number | 5; 1 |
Strength Unit | ug/1; mg/1 |
Pharmaceutical Classes | Progesterone Congeners [Chemical/Ingredient],Progestin [EPC],Estrogen [EPC],Estrogen Receptor Agonists [MoA] |